LIFONEBART
UNII S47D5D5UVS

Substance Identification & Data

This profile provides standardized clinical and technical data for Lifonebart, uniquely identified by the FDA Unique Ingredient Identifier (UNII) S47D5D5UVS.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 3056296-07-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

S47D5D5UVS

CAS Registry Number

3056296-07-9

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

LIFONEBART

Official standardized name for this substance within the FDA UNII nomenclature system.

INN ID

13851

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Lifonebart. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

LIFONEBART

Common Names & Synonyms

H-GAMMA1 HEAVY CHAIN HOMO SAPIENS (1-449) (VH (HOMO SAPIENS IGHV1-2*02 (92.9%) -(IGHD) -IGHJ4*01 (100%), CDR-IMGT (8.8.12) (26-33.51-58.97-108)) (1-119) -HOMO SAPIENS IGHG1*03, G1M3, NG1M1 CH1 R120, CH3 E12, M14, 1-G1V66 CH2 A27, 6-G1V4 CH2 A114, 9-G1V24 CH3 L107, S114 (CH1 R120 (216) (120-217), HINGE 1-15 (218-232), CH2 D27>A (267), P114>A (331) (233-342), CH3 E12 (358), M14 (360), M107>L (430), N114>S (436) (343-447), CHS (448-449)) (120-449)), (222-215')-DISULFIDE WITH L-KAPPA LIGHT CHAIN HOMO SAPIENS (1'-215') (V-KAPPA (HOMO SAPIENS IGKV1-16*01 (91.6%) -IGKJ1*01 (100%), CDR-IMGT (6.3.10) (27'-32'.50'-52'.89'-98')) (1'-108') -HOMO SAPIENS IGKC*01 (100%) KM3 A45.1, V101 (C-KAPPA A45.1 (154'), V101 (192')) (109'-215')); DIMER (228-228'':231-231'')-BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, CELL LINE CHO-K1, GLYCOFORM ALFA

IMMUNOGLOBULIN G1 (267-ALANINE,331-ALANINE,430-LEUCINE,436-SERINE), ANTI-(HUMAN TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 2) (HUMAN MONOCLONAL RITM7457671 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL RITM7457671 .KAPPA.-CHAIN, DIMER

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS TREM2 (TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 2)), HOMO SAPIENS MONOCLONAL ANTIBODY (LIFONEBART)

LIFONEBART [INN]

External Clinical & Regulatory Resources

Previous UNIIS479Q4IP0D

Next UNIIS47P2YLH0U